Arax Advisory Partners’s Columbia Research Enhanced Value ETF REVS Stock Holding History
Bought
Maintained
Sold
Other funds holding REVS
Arax Advisory Partners's REVS Position: Q3 2026 in Review
Arax Advisory Partners reduced its Columbia Research Enhanced Value ETF (REVS) stake by 1.3% in Q3 2026, selling an estimated $106K and leaving 236,423 shares worth $7.76M. The position accounts for 0.04% of the portfolio, ranked #418.
Arax Advisory Partners first reported a position in REVS in Q2 2026 and has held it in 2 quarters since. 32 funds tracked by Wall St. Rank hold REVS as of Q3 2026.
- Arax Advisory Partners held 236,423 shares of Columbia Research Enhanced Value ETF worth $7.76M as of Q3 2026.
- Arax Advisory Partners sold 3,192 Columbia Research Enhanced Value ETF shares in Q3 2026, an estimated $106K.
- Columbia Research Enhanced Value ETF made up 0.04% of Arax Advisory Partners's portfolio in Q3 2026, its #418 holding.
- Arax Advisory Partners first reported a position in Columbia Research Enhanced Value ETF in Q2 2026 and has held it in 2 quarters since.
- 32 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q3 2026.
Based on Arax Advisory Partners's 13F filing for Q3 2026, filed 12 Nov 2026.